Abtak Logo

medication News

Stay updated with the latest medication news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on medication topics.

Deccan Chronicle - Business - News Image
soure image
3
BusinessSep 27, 2025 01:54 AM

Pharma Tariff May Not Hit Hyd Drug Firms

HYDERABAD: Even as Donald Trump dashed off a missive announcing 100 per cent tariffs on branded, patented pharma products, Hyderabad, which has a significant number of pharma companies exporting to the US, may not see an impact, said industry officials. "The announcement is vague. The use of terms branded and patent in the message leaves scope for varied interpretation. India is predominantly a generic exporter and I don't think it impacts Hyderabad or even India," said R Udaya Bhasker, former ...Read More >

Abtak.com - Health - News Image
soure image
16
HealthSep 27, 2025 01:09 AM

How to Choose the Best IVF Clinic in Chennai: A Comprehensive Guide

VMPLNew Delhi [India], September 25: One of the most important things a person should do when confronted with fertility problems is to select a suitable IVF clinic. How to choose the best IVF clinic in Chennai is not just about being famous or getting the most significant number of advertisements. It means knowing the factors that have a direct impact on your getting pregnant successfully. A woman in her late 20s or 30s, a couple that has been struggling with infertility, an international patien ...Read More >

Abtak.com - Health - News Image
soure image
29
HealthSep 26, 2025 11:17 PM

Dangerous spike in superbug infections surges across US as experts share cautions

Gastroenterologist Dr. Joseph Salhab joins 'Fox & Friends' to examine a new study on the effects of pathogenic gut bacteria and tips for limiting exposure to harmful bacteria. Human infections from drug-resistant bacteria are spiking in the U.S., the Centers for Disease Control and Prevention has warned. The CDC's laboratory tests have shown that occurrences of a bacteria called NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE) have increased dramatically. NDM-CRE belongs to a bro ...Read More >

Deccan Chronicle - Politics - News Image
soure image
39
PoliticsSep 26, 2025 08:37 PM

India Expects a Partial or Full Rollback on Hefty Tariff Imposed on Pharma Produc

New Delhi: With the cent percent tariff imposed by the US on imports of branded and patented pharmaceutical drugs, starting October 1, 2025 across the board, including India, New Delhi on Friday did not react officially though, the government, however, is confident that India will continue to engage with the US officials even after the meeting held from September 22-24, and a decision to roll back -- either fully or partially -- on such 'hefty' tariff, especially on pharma products, is expected ...Read More >

Fortune India - Business - News Image
soure image
36
BusinessSep 26, 2025 07:14 PM

India closely monitoring impact of Trump's 100% tariff on branded pharma imports: MEA

Ministry of External Affairs (MEA) Official Spokesperson Randhir Jaiswal, reacting to US President Donald Trump's imposition of 100% tariffs on imports of branded and patented pharmaceutical drugs from October 1, 2025, said the government is monitoring the situation closely. On Thursday, the Trump administration announced that starting October 1, 2025, it will be imposing a 100% tariff on any branded or patented pharmaceutical product, unless a company is building their pharmaceutical manufactu ...Read More >

NewsDrum - Business - News Image
soure image
33
BusinessSep 26, 2025 06:41 PM

India, US to continue engagement for early conclusion of trade pact

New Delhi, Sep 26 (PTI) India and the US have decided to continue negotiations for early conclusion of a mutually beneficial bilateral trade agreement, the Commerce Ministry said on Friday. The statement was issued after the return of the Indian official delegation led by Commerce and Industry Minister Piyush Goyal to New York for trade talks. The delegation returned on September 24 after holding three-day talks. Both sides held constructive meetings on various aspects of the trade deal, the ...Read More >

Daily Times - Politics - News Image
soure image
20
PoliticsSep 26, 2025 06:18 PM

US hits Indian pharma with 100% tariff in bold trade move

Published on: September 26, 2025 5:46 PM The United States has announced a 100% tariff on Indian pharmaceutical imports, deepening trade tensions between the two countries. US President Donald Trump made the announcement on his social media platform, Truth Social. The new tariff will take effect from October 1. However, Trump said companies opening drug manufacturing plants in the US will be exempt. He cited national security as the main reason for the decision. India is among the world's larg ...Read More >

LatestLY - Business - News Image
soure image
15
BusinessSep 26, 2025 06:04 PM

India News | Shimla Patients Get Relief as New GST Reforms Reduce Medicine Prices by Up to 10 Per Ce...

Shimla (Himachal Pradesh) [India], September 26 (ANI): The Pharmaceutical companies and chemists in Shimla have begun implementing the revised GST night tariff on medicines, bringing much-needed relief to patients and the poor. Managers and pharmacy owners in the capital confirmed that the new reforms, effective as of September 22, have already reduced the prices of many essential and life-saving medications. Mahesh Bisht, Manager at a pharmaceutical company, explained the changes, "From Septem ...Read More >

NewsDrum - Business - News Image
soure image
22
BusinessSep 26, 2025 04:37 PM

Sensex, Nifty tank nearly 1 pc on selling in pharma, IT shares after new Trump tariffs on drugs

Mumbai, Sep 26 (PTI) Benchmark stock indices Sensex and Nifty tumbled nearly 1 per cent on Friday, marking their sixth consecutive day of decline, following heavy selling in pharma and IT shares as US President Donald Trump announced 100 per cent duties on pharmaceutical drugs from next month. The 30-share BSE Sensex tanked 733.22 points or 0.90 per cent to settle at a three-week low of 80,426.46. During the day, it dropped 827.27 points or 1 per cent to 80,332.41. The 50-share NSE Nifty tumbl ...Read More >

NewsDrum - Business - News Image
soure image
19
BusinessSep 26, 2025 03:32 PM

Trump's 100 pc tariff on pharma unlikely to have adverse impact on domestic industry: Experts

New Delhi, Sep 26 (PTI) US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 is unlikely to have an immediate impact on Indian exports, as it will affect only patented and branded products, not generic medicines, pharma industry players said on Friday. Indian Pharmaceutical Alliance (IPA), which represents 23 leading Indian pharmaceutical firms, including Dr Reddy's Laboratories, Sun Pharma, Lupin and Zydus Lifesciences, noted that Trump' ...Read More >

Lagatar English - Business - News Image
soure image
32
BusinessSep 26, 2025 03:23 PM

Trump's 100% Tariffs on Pharma: Which Indian Stocks Are at Risk?

New Delhi: US President Donald Trump's decision to impose 100% tariffs on branded and patented drug exports has shaken Indian pharmaceutical markets, despite most of India's $10 billion US sales being in generics. The uncertainty lies in whether complex generics and specialty medicines will be included, a move that could directly impact leading players like Sun Pharma, Dr. Reddy's, Cipla, Zydus Lifesciences, and others. Stocks Facing Highest Exposure Dr. Reddy's emerges as the most vulnerable, ...Read More >

ANI News - Business - News Image
soure image
16
BusinessSep 26, 2025 02:00 PM

European drugmakers to bear brunt of new U.S. tariffs, India less exposed: GTRI

New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >

ANI News - Politics - News Image
soure image
20
PoliticsSep 26, 2025 12:51 PM

100% US tariffs on branded pharma imports not likely to affect Indian generic drugs, says industry e...

New Delhi [India], September 26 (ANI): India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA). Speaking to ANI on Friday, Jain said that India's exports to the US primarily consist of generic drugs and active pharmaceutical ingredients (APIs), which are not covered under this tarif ...Read More >

ANI News - Politics - News Image
soure image
21
PoliticsSep 26, 2025 11:49 AM

Trump declares 100% tariff on pharma; not applicable to generic medicines, says industry leaders

New Delhi [India], September 26 (ANI):Indian Pharmaceutical Alliance has said that the US President Donald Trump's announcement of tariffs of up to 100 per cent on imports of branded and patented pharmaceuticals starting October 1 specifically refers to patented or branded products, and not impact generic medicines. Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said, "The executive order refers to patented / branded products supplied to the US. It is not applicable to ge ...Read More >

News18 - Business - News Image
soure image
19
BusinessSep 26, 2025 11:06 AM

Trump's 100 pc tariff on pharma will not impact generic makers: IPA

New Delhi, Sep 26 (PTI) Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines. Reacting to the development, IPA Secretary General Sudarshan Jain said in a statement, "It is not applicable to generics medicines." Trump's statement refers to patented and branded products supplied to US, he added. In his post on social me ...Read More >

LatestLY - Business - News Image
soure image
24
BusinessSep 26, 2025 11:02 AM

Stock Market Today: Sensex, Nifty Open Lower Over Donald Trump's 100% Tariffs on Branded and Patente...

Mumbai, September 26: The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and patented pharmace ...Read More >

NewsDrum - Business - News Image
soure image
34
BusinessSep 26, 2025 11:01 AM

Pharma stocks decline; Wockhardt tumbles over 6 pc

New Delhi, Sep 26 (PTI) Pharma stocks fell in morning trade on Friday as investors grew concerned after US President Donald Trump announced import taxes of 100 per cent on branded and patented pharmaceutical drugs. Wockhardt Ltd tumbled 6.58 per cent, Natco Pharma tanked 5.46 per cent, Sun Pharma dropped 4.96 per cent, Indoco Remedies edged lower by 4.70 per cent, Glenmark Pharma fell by 2.88 per cent, Aurobindo Pharma 2.44 per cent and Dr Reddys dipped 2.31 per cent on the BSE. The BSE health ...Read More >

Social News XYZ - Business - News Image
soure image
20
BusinessSep 26, 2025 10:01 AM

Sensex, Nifty open lower over Trump's tariffs on pharma imports

Mumbai, Sep 26 (SocialNews.XYZ) The Indian benchmark indices opened lower on Friday, following US President Donald Trump's announcement of tariffs on pharma imports and sustained selling by foreign institutional investors. As of 9.25 am, Sensex was down 388 points, or 0.48 per cent at 80,771 and Nifty was down 119 points, or 0.48 per cent at 24,771. Shares of Indian and other Asian pharmaceutical companies fell after Trump announced tariffs of up to 100 per cent on imports of branded and paten ...Read More >

LatestLY - Business - News Image
soure image
9
BusinessSep 26, 2025 09:32 AM

Business News | Trump's 100% Tariff on Patented Drugs Puts Spotlight on India's USD 30 Billion Pharm...

New Delhi [India], September 26 (ANI): United States President Donald Trump announced on Friday that his administration will impose a 100 per cent tariff on branded and patented pharmaceutical products beginning October 1, 2025, unless the manufacturing companies establish production facilities in the United States. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicines in the UK. ...Read More >

Yahoo! Finance - Business - News Image
soure image
16
BusinessSep 26, 2025 08:55 AM

Rupee's rough patch may extend as Trump fires fresh tariff salvo

MUMBAI (Reuters) -The Indian rupee is likely to stay under pressure on Friday and could slip to an all-time low after U.S. President Donald Trump unveiled a new round of tariffs, including a 100% duty on any branded or patented pharmaceutical products. The 1-month non-deliverable forward indicated the rupee will open around the all-time low of 88.7975 hit earlier this week, compared with Thursday's close of 88.6650. Meanwhile, on Thursday, Trump said duties on branded drugs, heavy-duty trucks ...Read More >

Times Bull - Other - News Image
soure image
12
OtherSep 26, 2025 07:47 AM

Trump drops another bombshell, imposes 100% tariff, causing uproar - Times Bull

New Delhi: US President Donald Trump has once again dropped a tariff bomb. This time, many countries around the world, including India, have been hit by the Trump bomb. Donald Trump has announced a 100% tariff on pharmaceutical imports. This means that medicines will now be subject to a 100% tariff. This is being considered a major blow to countries that export medicines to the US. India also exports a significant amount of pharmaceutical goods. Donald Trump surprised everyone by sharing this i ...Read More >

Abtak.com - Health - News Image
soure image
16
HealthSep 26, 2025 04:07 AM

Lilly plans to launch experimental weight-loss pill in India, exec says

MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >

Abtak.com - Health - News Image
soure image
26
HealthSep 26, 2025 03:10 AM

CDC warns of surge in dangerous, highly antibiotic-resistant bacteria

This advertisement has not loaded yet, but your article continues below. NDM-CRE infections have been historically uncommon in the United States, the CDC said. The NDM gene - which was first identified in 2008 from a Swedish patient who had been hospitalized in New Delhi - creates an enzyme that destroys most antibiotics, including so-called carbapenems, which are usually used in last-ditch efforts to save patients with infections that fail to respond to standard antibiotics, The Washington Pos ...Read More >

fallback-img
soure image
13
HealthSep 26, 2025 02:37 AM

Service rules for pharmacists delayed for remarkable 53 yrs!

SHILLONG, Sep 25: Fifty-three years since Meghalaya attained statehood in 1972 and the state is yet to finalise service rules for pharmacists. This limbo is hampering the functioning of health centres across the state as the government remains unable to make new appointments to address staff shortages. Over time, a severe shortage of pharmacists, particularly in remote areas, has come to the fore. Speaking to reporters on Thursday, Meghalaya Government Pharmacists Association (MGPA) secretary L ...Read More >

Social News XYZ - Politics - News Image
soure image
6
PoliticsSep 23, 2025 04:47 PM

Twin India meetings in US open avenues for renewing ties

New Delhi, Sep 23 (SocialNews.XYZ) India continued to pursue pragmatic solutions to the challenges posed by the current world trade order. New Delhi exhibited patience, resilience while resorting to appropriate and opportune diplomatic interventions. Monday's twin meetings in the United States underscore such attempts. In Washington, Commerce and Industries Minister Piyush Goyal's trade engagement focused on the resumption of trade talks. Meanwhile, in New York, the same day, External Affairs ...Read More >

fallback-img
soure image
31
BusinessSep 16, 2025 02:25 PM

India's exports robust led by electronic, engineering and petroleum products

New Delhi, Sep 16 (UNI) India's merchandise exports rose to USD 35.10 billion in August 2025 compared to USD 32.29 billion in August 2024 , said the Ministry of Commerce and Industry. Moreover, the country's imports remained at USD 61.59 billion in August 2025, compared to USD 68.53 billion of the same period in previous year, showing a decline, said the statement. "The cumulative exports (merchandise and services) during April-August 2025 are estimated at USD 349.35 billion as compared to USD ...Read More >

The Times of India - Other Politics Business Health - News Image
soure image
24
OtherPoliticsBusinessHealthSep 16, 2025 08:32 AM

Delhi govt to clear ₹140 crore pending EV subsidy dues after High Court order

New Delhi: The Delhi government will soon begin clearing pending electric vehicle (EV) subsidy dues amounting to about ₹140 crore, officials said on Monday as per PTI. Transport Minister Pankaj Singh confirmed that the department will verify all subsidy applications to resolve the backlog, which has piled up over the past two years. "The process of identifying eligible beneficiaries has already started," an official said. A dedicated portal for clearing dues is also being prepared. The develop ...Read More >

The Hans India - Health - News Image
soure image
17
HealthSep 16, 2025 08:26 AM

TG govt axes school turned drug lab; relocates displaced students

Hyderabad: A stunning revelation has rocked Hyderabad as police uncovered a covert alprazolam manufacturing unit operating inside Medha School, Bowenpally, in an operation led by the Elite Action Group for Drug Law Enforcement (EAGLE). Authorities seized over 7 kg of alprazolam, including 3.5 kg of finished product and 4.3 kg of semi-processed tablets, alongside raw materials and state-of-the-art manufacturing equipment. Along with the drugs, cash amounting to 21 lakh was recovered from the scho ...Read More >

The Times of India - Business - News Image
soure image
16
BusinessSep 16, 2025 01:49 AM

Government seeks to identify 100 products in local manufacturing push - The Times of India

NEW DELHI: To drive self-sufficiency, the commerce department is identifying 100-odd products for a local manufacturing push where domestic players depend on imports currently, a top official said Monday.The swadeshi initiative is expected to see products from across sectors - engineering goods, chemicals, plastics and pharma - being identified for possible import substitution. "We have identified around 100 products with large imports that also have large domestic capacity. We want to see if ca ...Read More >

Social News XYZ - Business - News Image
soure image
7
BusinessSep 15, 2025 07:48 PM

AI could add $1.9 trillion to Indian economy by 2035: NITI Aayog

New Delhi, Sep 15 (SocialNews.XYZ) Artificial Intelligence has the power to transform India's economic growth in the coming decade as it could add up to $1.9 trillion to the country's economy by 2035, according to a new report by NITI Aayog on Monday. Globally, AI adoption is expected to generate $17-26 trillion in value over the next ten years, as per the report titled 'AI for Viksit Bharat: Roadmap for Accelerated Economic Growth'. India has the potential to capture 10-15 per cent of this va ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.